116 related articles for article (PubMed ID: 3276761)
1. An open study of auranofin in the treatment of steroid-dependent asthma.
Bernstein DI; Bernstein IL; Bodenheimer SS; Pietrusko RG
J Allergy Clin Immunol; 1988 Jan; 81(1):6-16. PubMed ID: 3276761
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial.
Bernstein IL; Bernstein DI; Dubb JW; Faiferman I; Wallin B
J Allergy Clin Immunol; 1996 Aug; 98(2):317-24. PubMed ID: 8757209
[TBL] [Abstract][Full Text] [Related]
3. [The effect of an oral gold compound, auranofin, on bronchial responsiveness to inhaled methacholine in well-controlled bronchial asthma].
Honma M; Tamura G; Taniguchi Y; Takishima T
Arerugi; 1991 Dec; 40(12):1470-6. PubMed ID: 1793366
[TBL] [Abstract][Full Text] [Related]
4. Effect of an oral gold compound, auranofin, on non-specific bronchial hyperresponsiveness in mild asthma.
Honma M; Tamura G; Shirato K; Takishima T
Thorax; 1994 Jul; 49(7):649-51. PubMed ID: 8066558
[TBL] [Abstract][Full Text] [Related]
5. Auranofin in the treatment of steroid dependent asthma: a double blind study.
Nierop G; Gijzel WP; Bel EH; Zwinderman AH; Dijkman JH
Thorax; 1992 May; 47(5):349-54. PubMed ID: 1609377
[TBL] [Abstract][Full Text] [Related]
6. Effect of corticosteroids on bronchial responsiveness to methacholine in asthmatic children.
Bhagat RG; Grunstein MM
Am Rev Respir Dis; 1985 Jun; 131(6):902-6. PubMed ID: 3890642
[TBL] [Abstract][Full Text] [Related]
7. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
[TBL] [Abstract][Full Text] [Related]
8. Circadian rhythm in airway responsiveness and airway tone in patients with mild asthma.
Bonnet R; Jörres R; Heitmann U; Magnussen H
J Appl Physiol (1985); 1991 Oct; 71(4):1598-605. PubMed ID: 1757388
[TBL] [Abstract][Full Text] [Related]
9. Influence of posture on expiratory flows and airway responsiveness to methacholine in asthma.
Tahan M; Boulet LP
Chest; 1993 Jul; 104(1):143-8. PubMed ID: 8325059
[TBL] [Abstract][Full Text] [Related]
10. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission.
Boulet LP; Turcotte H; Brochu A
Chest; 1994 Apr; 105(4):1024-31. PubMed ID: 8162720
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
12. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma.
Juniper EF; Frith PA; Hargreave FE
Thorax; 1981 Aug; 36(8):575-9. PubMed ID: 7031972
[TBL] [Abstract][Full Text] [Related]
13. Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma.
Gagnon M; Côte J; Milot J; Turcotte H; Boulet LP
Chest; 1994 Jun; 105(6):1732-7. PubMed ID: 8205868
[TBL] [Abstract][Full Text] [Related]
14. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
15. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
[TBL] [Abstract][Full Text] [Related]
16. Deep inspiration avoidance and methacholine response in normal subjects and patients with asthma.
Simard B; Turcotte H; Cockcroft DW; Davis BE; Boulay ME; Boulet LP
Chest; 2005 Jan; 127(1):135-42. PubMed ID: 15653974
[TBL] [Abstract][Full Text] [Related]
17. Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm.
Kacmarek RM; Ripple R; Cockrill BA; Bloch KJ; Zapol WM; Johnson DC
Am J Respir Crit Care Med; 1996 Jan; 153(1):128-35. PubMed ID: 8542105
[TBL] [Abstract][Full Text] [Related]
18. The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
Blais CM; Davis BE; Cockcroft DW
Respir Res; 2017 Aug; 18(1):146. PubMed ID: 28768531
[TBL] [Abstract][Full Text] [Related]
19. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects.
Bel EH; Timmers MC; Hermans J; Dijkman JH; Sterk PJ
Am Rev Respir Dis; 1990 Jan; 141(1):21-8. PubMed ID: 2153355
[TBL] [Abstract][Full Text] [Related]
20. Dose response of inhaled gallopamil (D600), a calcium channel blocker, in attenuating airway reactivity to methacholine and exercise.
Massey KL; Hill M; Harman E; Rutledge DR; Ahrens R; Hendeles L
J Allergy Clin Immunol; 1988 May; 81(5 Pt 1):912-8. PubMed ID: 3286722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
